Christine Curcio

Christine Curcio

Company: University of Alabama at Birmingham

Job title: Professor – Ophthalmology & Director – Age-Related Maculopathy Histopathology Lab

Bio:

Christine A. Curcio PhD is White-McKee Endowed Professor of Ophthalmology and Visual Sciences at the University of Alabama at Birmingham School of Medicine (Birmingham, Alabama, USA). She collaborates with innovative eye banks to investigate human retinal neuroscience, aging, and age-related macular degeneration (AMD). She has focused on pathobiology (especially drusen and outer retinal degeneration) and validation of clinical retinal imaging technology, including optical coherence tomography, fundus autofluorescence, and adaptive optics-assisted outer retinal imaging. Her maps of the human photoreceptor layer provided a basis for rod-mediated dark adaptometry as a functional test for AMD. Since 1984, research resulting in ~200 peer review articles and >250 invited presentations has been funded by the National Institutes of Health, foundations, and industry. She serves on editorial boards of Investigative Ophthalmology & Visual Science and Retina. She was awarded the 2002 (inaugural) Roger H. Johnson Prize for Macular Degeneration research, the 2014 Ludwig von Sallmann Prize, and the 2020 Research to Prevent Blindness – David F. Weeks Award for excellence in AMD research. Dr. Curcio provides histology to the Classification of Atrophy group, a clinical international consensus group that is defining OCT-based imaging endpoints for AMD clinical trials. Collaborative clinicopathologic correlation with K.B. Freund MD has validated imaging of retinal neovascularization morphologies.

Seminars:

Chair Led Q&A: Ensuring Clinical Success for the Emerging Therapeutic Approaches in the Management of Wet AMD & DME 10:00 am

How can we improve the current standard-of-care & ensure the clinical success of future clinical approaches?Read more

day: Day One

Two Ways to Achieve Clinical Success: Two Vascular Systems of the Retina 9:35 am

Successful treatments building on a comprehensive understanding of retinal vascular biology and pathology. Layer-by-layer visualization of neovascularization types by optical coherence tomography leading to consensus nomenclature based on the laminar position of neovascularization at presentation Understanding the implications for molecular targets, outcome measures, trial participant enrollment, and education of physicians, patients, and families about treatment…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.